Inga Nehlmeier

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Markus Hoffmann, Nadine Krüger, Sebastian Schulz et al. · Cell · 2021 · 955 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease

Stephanie Bertram, Ilona Glowacka, Marcel A. Müller et al. · Journal of Virology · 2011 · 353 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger et al. · Cell Reports · 2021 · 242 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

Lu Zhang, Amy Kempf, Inga Nehlmeier et al. · Cell · 2024 · 121 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +7

Glycan-Gold Nanoparticles as Multifunctional Probes for Multivalent Lectin–Carbohydrate Binding: Implications for Blocking Virus Infection and Nanoparticle Assembly

Darshita Budhadev, Emma Poole, Inga Nehlmeier et al. · Journal of the American Chemical Society · 2020 · 97 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17